Related Experiment Video
Updated: Feb 13, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer
Somrudee Reabroi1, Arthit Chairoungdua2, Rungnapha Saeeng3
1Department of Physiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Abstract:
Hyperactivation of Wnt/β-catenin signaling implicated in oncogenesis of colorectal cancer (CRC) is a potential molecular target for chemotherapy. An andrographolide analogue, 3A.1 (19-tert-butyldiphenylsilyl-8, 17-epoxy andrographolide) has previously been reported to be potently cytotoxic toward cancer cells by unknown molecular mechanisms. The present study explored the anti-cancer activity of analogue 3A.1 on Wnt/β-catenin signaling in colon cancer cells (HT29 cells) which were more sensitive to the others (HCT116 and SW480 cells). Analogue 3A.1 inhibited viability of HT29 cells with IC50 value of 11.1 ± 1.4 μM at 24 h, which was more potent than that of the parent andrographolide. Analogue 3A.1 also suppressed the proliferation of HT29 cells and induced cell apoptosis in a dose-dependent manner. Its apoptotic activity was accompanied with increased expressions of proteins related to DNA damages; PARP-1 and γ-H2AX. In addition, analogue 3A.1 significantly inhibited T-cell factor and lymphoid enhancer factor (TCF/LEF) promoter activity of Wnt/β-catenin signaling. Accordingly, the expressions of Wnt target genes and β-catenin protein were suppressed. Moreover, analogue 3A.1 increased the activity of GSK-3β kinase, which is a negative regulator responsible for degradation of intracellular β-catenin. This mode of action was further supported by the absence of the effects after treatment with a GSK-3β inhibitor, and over-expression of a mutant β-catenin (S33Y). Our findings reveal, for the first time, an insight into the molecular mechanism of the anti-cancer activity of analogue 3A.1 through the inhibition of Wnt/β-catenin/GSK-3β pathway and provide a therapeutic potential of the andrographolide analogue 3A.1 in CRC treatment.
Insights
Andrographolide analogue 3A.1 effectively inhibits colorectal cancer (CRC) cell growth by targeting the Wnt/β-catenin/GSK-3β pathway. This compound shows therapeutic potential for CRC treatment by inducing apoptosis and DNA damage.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Hyperactivation of Wnt/β-catenin signaling is a key driver in colorectal cancer (CRC) oncogenesis.
- Andrographolide analogue 3A.1 exhibits potent cytotoxicity against cancer cells via unknown mechanisms.
- Colon cancer HT29 cells demonstrate higher sensitivity to analogue 3A.1 compared to HCT116 and SW480 cells.
Purpose of the Study:
- To investigate the anti-cancer activity of andrographolide analogue 3A.1 on Wnt/β-catenin signaling in HT29 colon cancer cells.
- To elucidate the molecular mechanisms underlying the cytotoxic effects of analogue 3A.1.
- To evaluate the therapeutic potential of analogue 3A.1 in colorectal cancer treatment.
Main Methods:
- Assessing cell viability and proliferation using IC50 values and dose-dependent assays.
- Analyzing apoptosis induction and DNA damage markers (PARP-1, γ-H2AX).
- Measuring T-cell factor/lymphoid enhancer factor (TCF/LEF) promoter activity and Wnt target gene/β-catenin expression.
- Evaluating the role of GSK-3β kinase activity and using GSK-3β inhibitor and mutant β-catenin.
Main Results:
- Analogue 3A.1 significantly inhibited HT29 cell viability (IC50: 11.1 ± 1.4 μM at 24h) and proliferation, inducing apoptosis.
- Apoptosis was associated with increased DNA damage markers PARP-1 and γ-H2AX.
- Analogue 3A.1 suppressed Wnt/β-catenin signaling by inhibiting TCF/LEF promoter activity, downregulating Wnt target genes and β-catenin protein.
- Increased GSK-3β kinase activity was observed, with effects blocked by GSK-3β inhibitor and mutant β-catenin.
Conclusions:
- Analogue 3A.1 exerts anti-cancer effects by inhibiting the Wnt/β-catenin/GSK-3β pathway in colon cancer cells.
- The compound induces DNA damage and apoptosis, contributing to its cytotoxic activity.
- Andrographolide analogue 3A.1 demonstrates significant therapeutic potential for colorectal cancer treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
TGF - β Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway

